Gender differences in the association between HDL cholesterol and the progression of diabetic kidney disease in type 2 diabetic patients

Nephrology Dialysis Transplantation

Volumn 27, Issue 3, 2012, Pages 1070-1075

  Hanai, Ko ^a   Babazono, Tetsuya ^a   Yoshida, Naoshi ^a   Nyumura, Izumi ^a   Toya, Kiwako ^a   Hayashi, Toshihide ^a   Bouchi, Ryotaro ^a   Tanaka, Nobue ^a   Ishii, Akiko ^a   Iwamoto, Yasuhiko ^a  

^a TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

Author keywords

Albuminuria; Diabetic kidney disease; Gender differences; HDL cholesterol

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; AGED; ARTICLE; CHOLESTEROL BLOOD LEVEL; COHORT ANALYSIS; CONTROLLED STUDY; DIABETIC NEPHROPATHY; DISEASE ASSOCIATION; DISEASE COURSE; FEMALE; FOLLOW UP; HIGH RISK PATIENT; HUMAN; JAPANESE; MAJOR CLINICAL STUDY; MALE; MICROALBUMINURIA; NON INSULIN DEPENDENT DIABETES MELLITUS; OUTCOME ASSESSMENT; PATIENT ASSESSMENT; PRIORITY JOURNAL; SEX DIFFERENCE;

ADULT; AGED; AGED, 80 AND OVER; ALBUMINURIA; CHOLESTEROL, HDL; COHORT STUDIES; DIABETES COMPLICATIONS; DIABETES MELLITUS, TYPE 2; DIABETIC NEPHROPATHIES; FEMALE; FOLLOW-UP STUDIES; GLOMERULAR FILTRATION RATE; HUMANS; INCIDENCE; JAPAN; MALE; MIDDLE AGED; PROGNOSIS; RISK FACTORS; SEX FACTORS; TRIGLYCERIDES; YOUNG ADULT;

EID: 84861123746     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfr417     Document Type: Article

References (19)

1. Colhoun HM, Lee ET, Bennett PH et al. Risk factors for renal failure. Diabetologia 2001; 44(Suppl 2):S46-S53
2. Retnakaran R, Cull CA, Thorne KI et al. Risk factors for renal dysfunction in type 2 diabetes. Diabetes 2006; 55: 1832-1839
3. Sun L, Halaihel N, Zhang W et al. Role of sterol regulatory elementbinding protein 1 in regulation of renal lipid metabolism and glomerulosclerosis in diabetes mellitus. J BiolChem2002; 277: 18919-18927
4. Wang Z, Jiang T, Li J et al. Regulation of renal lipid metabolism, lipid accumulation, and glomerulosclerosis in FVBdb/db mice with type 2 diabetes. Diabetes 2005; 54: 2328-2335
5. Tu ST, Chang SJ, Chen JF et al. Prevention of diabetic nephropathy by tight target control in an Asian population with type 2 diabetes mellitus. Arch Intern Med 2010; 170: 155-161
6. Xu J, Lee ET, Devereux RB et al. A longitudinal study of risk factors for incident albuminuria in diabetic American Indians: The Strong Heart Study. Am J Kidney Dis 2008; 51: 415-424
7. Lin J, Hu FB, Mantzoros C, Curhan GC. Lipid and inflammatory biomarkers and kidney function decline in type 2 diabetes. Diabetologia 2010; 53: 263-267
8. Halbesma N, Brantsma AH, Bakkar SJL et al. Gender differences in predictors of the decline of renal function in the general population. Kidney Int 2008; 74: 505-512
9. Lin J, Hu FB, Rimm EB et al. The association of serum lipids and inflammatory biomarker with renal function in men with type II diabetes mellitus. Kidney Int 2006; 69: 336-342
10. The committee of the Japan Diabetes Society on the diagnostic criteria of diabetes mellitus. Kuzuya T, Nakagawa S et al. Rport of the committee on the classification and diagnostic criteria of diabetes mellitus. Diabetes Res Clin Pract. 2002; 55: 65-85
11. American Diabetes Association. Nephropathy in diabetes. Diabetes Care 2004; 27 (Suppl 1):S79-S83
12. Matsuo S, Imai E, Horio M et al. Revised equations for estimated GFR from serum creatinine in Japan. Am J Kidney Dis 2009; 53: 982-992
13. Seino Y, Nanjo K, Tajima N et al. Report of the committee on the classification and diagnostic criteria of diabetes mellitus. Diabetol Int 2010; 1: 2-20
14. Barter PJ, Nicholls S, Rye KA et al. Antiinflammatory properties of HDL. Circ Res 2004; 95: 764-772
15. Yanes LL, Sartori-Valinotti JC, Reckelhoff JF. Sex steroids and renal disease. Hypertension 2008; 51: 976-981
16. Fortepiani LA, Reckelhoff JF. Role of oxidative stress in the sex differences in blood pressure in spontaneously hypertensive rats. J Hypertens 2005; 23: 801-805
17. Barter PJ, Caulfield M, Eriksson M et al. Effects of torcetrapib in patients at high risk for coronary events. N Engl J Med 2007; 357: 2109-2122
18. Tolonen N, Forsblom C, Thorn L et al. Lipid abnormalities predict progression of renal disease in patients with type 1 diabetes. Diabetologia 2009; 52: 2522-2530
19. Miida T, Sakai K, Ozaki K et al. Bezafibrate increases preß1-HDL at the expense of HDL2b in hypertriglyceridemia. Arterioscler Thromb Vasc Biol 2000; 20: 2428-2433